CCIA
ROIV icon

Campbell & Co Investment Adviser’s Roivant Sciences ROIV Stock Holding History

Campbell & Co Investment Adviser’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-35,753
Closed -$541K – 1368
2025
Q3 		$541K Sell
35,753
-68,705
-66% -$851K 0.04% 696
2025
Q2 		$1.18M Buy
104,458
+80,206
+331% +$869K 0.07% 436
2025
Q1 		$245K Sell
24,252
-53,759
-69% -$581K 0.02% 894
2024
Q4 		$923K Buy
+78,011
New +$922K 0.07% 425

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Campbell & Co Investment Adviser's ROIV Position: Q4 2025 in Review

Campbell & Co Investment Adviser sold out of Roivant Sciences (ROIV) in Q4 2025, closing a stake of 35,753 shares — an estimated $541K sold.

Campbell & Co Investment Adviser first reported a position in ROIV in Q4 2024 and held it in 4 quarters. The position peaked at $1.18M in Q2 2025. 396 funds tracked by Wall St. Rank hold ROIV as of Q4 2025.

  • Campbell & Co Investment Adviser reported no remaining Roivant Sciences position as of Q4 2025 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 35,753 Roivant Sciences shares in Q4 2025, an estimated $541K.
  • Campbell & Co Investment Adviser first reported a position in Roivant Sciences in Q4 2024 and held it in 4 quarters.
  • Campbell & Co Investment Adviser's Roivant Sciences position peaked at $1.18M in Q2 2025.
  • 396 funds tracked by Wall St. Rank held Roivant Sciences as of Q4 2025.

Based on Campbell & Co Investment Adviser's 13F filing for Q4 2025, filed 12 Feb 2026.